eFFECTOR Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/09/2024 | Q1 2024 | -$2.16 | $0 | |||
| 03/26/2024 | Q4 2023 | -$3.42 | $162,000 | |||
| 11/13/2023 | Q3 2023 | -$3.36 | $0 | |||
| 08/08/2023 | Q2 2023 | -$4.37 | $0 | |||
| 05/09/2023 | Q1 2023 | -$5.96 | $0 | |||
| 03/08/2023 | Q4 2022 | -$5.57 | $675,000 | |||
| 11/07/2022 | Q3 2022 | -$5.80 | $867,000 | |||
| 08/09/2022 | Q2 2022 | -$4.20 | $2.01 M | |||
| 05/10/2022 | Q1 2022 | $1.77 | $0 | |||
| 03/16/2022 | Q4 2021 | $11.79 | $1.43 M | |||
| 11/08/2021 | Q3 2021 | $5.50 | $427,000 | |||
| 08/12/2021 | Q2 2021 | -$6.15 | $692,000 | |||
| 06/03/2021 | Q1 2021 | -$11.00 | $0 | |||
| 03/29/2021 | Q4 2020 | -$0.66 | $42,000 | |||
| 09/29/2020 | Q3 2020 | -$12.71 | $574,000 | |||
| 06/29/2020 | Q2 2020 | $134.79 | $15.06 M | |||
| 03/30/2020 | Q1 2020 | $13.34 | $26.33 M |
eFFECTOR Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is eFFECTOR Therapeutics, Inc.'s earnings date?
eFFECTOR Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
-
How can I listen to eFFECTOR Therapeutics, Inc.'s earnings conference call?
The conference call for eFFECTOR Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read eFFECTOR Therapeutics, Inc.'s conference call transcript?
The conference call transcript for eFFECTOR Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does eFFECTOR Therapeutics, Inc. generate each year?
eFFECTOR Therapeutics, Inc. (:EFTRW) has a recorded net income of $0. eFFECTOR Therapeutics, Inc. has generated $-16.37 earnings per share over the last four quarters.
-
What is eFFECTOR Therapeutics, Inc.'s price-to-earnings ratio?
eFFECTOR Therapeutics, Inc. (:EFTRW) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is 0.
